Cytokinetics Inc (CYTK) stock news · rev $88.0M
Cytokinetics Inc (CYTK) is a biotechnology company listed on US.
This CYTK news page leads with what Cytokinetics Inc filed — not a scraped headline mill.
No cached 8-K sentence for CYTK yet. We will not pad this page with generic market recap.
Latest reported CYTK revenue for 2025-12-31 was $88.0M. Net income was -$785.0M. Revenue was up 376.6% from 2024-12-31 to 2025-12-31. CYTK currently screens at market cap $4.05B.
EDGAR remains the official archive. Lician caches the exhibit so you can read what changed without a wire story.
Not investment advice. For the model open the CYTK stock page; for the tape open the quote page.
CYTK stock news FAQ
What are CYTK's latest revenue and net income?
Latest cached Cytokinetics Inc (CYTK) revenue for Dec 31, 2025 was $88.0M. Net income was -$785.0M. Statements: https://lician.com/financials/cytk
How did CYTK revenue change from the prior cached period?
Cached Cytokinetics Inc (CYTK) revenue was up 376.6% from $18.5M (Dec 31, 2024) to $88.0M (Dec 31, 2025). Statements: https://lician.com/financials/cytk
What is CYTK's market cap?
Cytokinetics Inc (CYTK) market cap is $4.05B on the latest cached fundamentals snapshot.
What kind of company is CYTK?
Cytokinetics Inc (CYTK) is a biotechnology company listed on US.
Where is CYTK stock news listed?
Cached stock news for Cytokinetics Inc (CYTK) is listed at https://lician.com/news/cytk. Filings: https://lician.com/sec/cytk
Not investment advice.